Supply Chain Resources

In this Q&A with life science supply chain expert Marcos Buelvas, we explore present day challenges and opportunities as well as what's to come.

A clinical stage biotech company was developing an innovative product with medical applications spanning from trauma to wound care, imaging, targeted drug delivery, and regenerative medicine. The...

Data-driven insights are key to flourish in the post-pandemic economy, but it can be challenging to find resources to harness those insights effectively.

Mergers and acquisitions often go hand-in-hand with strategic cost reduction. See how independent talent delivered flexibility and cost savings for one energy leader.

A PE-backed fast-growing CPG co-manufacturer had a myriad of supply chain issues across their six siloed divisions. A recent acquisition only exacerbated their operational challenges. Their...

A large footwear brand needed a supply chain expert to act as a thought partner, driving a project focused on harmonizing and integrating supply chain operations and practices. After meeting an...

An F200 materials science company was revamping forecasting processes—including market, demand planning, analytics, and core skills—but did not have any forecasters on its current team. The Deputy...

Independent supply chain expert Priya Kumar shares her advice on how leading companies can optimize for supply chain resilience in 2022 and adapt to unforeseen challenges in a post-COVID world.

Senior IT consultant, executive, and blockchain expert Peter Wokwicz joins us to discuss a few of the biggest trends in enterprise blockchain, cryptocurrency, and decentralized finance.

As companies shift focus from triaging operations to long-term strategy, here are the top trends and opportunities to watch in the pandemic recovery phase.

As part of a company-wide growth mandate, the marketing VP and COO of a global chemicals manufacturer and distributor wanted to expand their supplier base, particularly outside the Chinese...

John O'Hara, VP of Strategic Initiatives at Janssen, joins us to discuss J&J's framework for ethical decision-making in pharma manufacturing and supply chain related to the COVID-19 pandemic

In response to the COVID-19 pandemic, a large home healthcare provider launched a crisis response initiative to prepare the company to safely provide services. Historically, this business...

Sandy Torrekens—Lead Strategist for the UK Dept. of Health during the “Swine Flu” pandemic—joins us to discuss how life science and pharma companies can respond to COVID-19 supply chain disruption.

Global supply chains are severely strained by the coronavirus (COVID-19) pandemic. Supply chain and manufacturing specialist Rosemary Coates discusses how companies can address the disruption.

Coronavirus is slowing global supply chains. Independent supply chain specialist Rosemary Coates explains how to build robust backup plans.